Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
MTPH.L Share News (MTPH)
MTPH Share
Price
MTPH Share
News
MTPH Share
Chat
MTPH Share
Trades
MTPH
Live RNS
MTPH Share
Charts
MTPH Broker
Ratings
MTPH Directors
Deals
MTPH Financial
Diary
MTPH
Fundamentals
MTPH Short
Positions
MTPH
Media
MTPH Company
Research
MTPH Company
Timeline
- There is currently no data for MTPH
MTPH.L News
Midatech Pharma Slims Interim Loss As Cancer Treatments Progress
Midatech Pharma Slims Interim Loss As Cancer Treatments Progress
Midatech Pharma Applies To US Regulator For Share Issue Authority
Midatech Pharma Applies To US Regulator For Share Issue Authority
Midatech Pharma gets approval for next MTD201 study
(Sharecast News) - Biotechnology company Midatech Pharma has received approval to commence a phase 1 study on MTD201, which it is developing for the t...
Midatech Pharma Secures Approval To Commence MTD201 First-Phase Study
(Alliance News) - Midatech Pharma PLC on Friday said it has received approval to start a first phase of study on MTD201, which it is developing for th...
Midatech Secures Spanish Government Loan To Fund MTD201 Cancer Drug
(Alliance News) - Midatech Pharma PLC's shares surged on Wednesday as said it has received a EUR6.6 million loan from the Spanish government to financ...
Midatech Pharma Appoints Former Ergomed CEO As Chief Financial Officer
(Alliance News) - Immunotherapy-focused pharmaceutical company Midatech Pharma PLC said Monday it has appointed Stephen Stamp as chief financial offic...
MidaTech Pharma Appoints Frederic Duchesne As Non-Executive Director
(Alliance News) - Midatech Pharma PLC said Wednesday that Frederic Duchesne had been appointed as a non-executive director, effective immediately.Duch...
Midatech Pharma Shares Surge After Positive Diabetes Treatment Results
(Alliance News) - Shares in biopharmaceutical firm Midatech Pharma PLC surged Friday after it received positive results from its first-in-human study ...
Follow the stocks
